Showing results (51-60 of 139) with videos related to
Sort By:
Pageof 14
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS StudyD Gareth R Evans, Fiona Lennard, Linda J Pointon, et al.Plos One|September 17, 2020
Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control studyMohammad Aladwani, Artitaya Lophatananon, Fredie Robinson, et al.Nature Communications|October 28, 2015
Identification of four new susceptibility loci for testicular germ cell tumourKevin Litchfield, Amy Holroyd, Amy Lloyd, et al.International Journal of Cancer|June 22, 2007
Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibilityJulian Barwell, Laurent Pangon, Anne Georgiou, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2015
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosisNora Pashayan, Stephen W Duffy, David E Neal, et al.Oncogene|November 29, 2020
FRMD6 has tumor suppressor functions in prostate cancerJakob Haldrup, Siri H Strand, Clara Cieza-Borrella, et al.The British Journal of Nutrition|January 20, 2010
Dietary fat and early-onset prostate cancer riskArtitaya Lophatananon, Jane Archer, Douglas Easton, et al.European Urology|December 12, 2018
Homeobox B13 G84E Mutation and Prostate Cancer RiskTommy Nyberg, Koveela Govindasami, Goska Leslie, et al.International Journal of Cancer|January 8, 2013
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer riskMadeleine M A Tilanus-Linthorst, Hester F Lingsma, D Gareth Evans, et al.Oncotarget|March 22, 2018
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancerChey Loveday, Kevin Litchfield, Max Levy, et al.Pageof 14